Silk Road Medical Inc. (SILK) Misses Q4 EPS by 6c, Revenues Beats
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts SILK Hot Sheet
Join SI Premium – FREE
Silk Road Medical Inc. (NASDAQ: SILK) reported Q4 EPS of ($0.42), $0.06 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $28.3 million versus the consensus estimate of $25.9 million.
GUIDANCE:
Silk Road Medical Inc. sees FY2022 revenue of $126-132 million, versus the consensus of $133.39 million.
For earnings history and earnings-related data on Silk Road Medical Inc. (SILK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- RBC Capital Reiterates Outperform Rating on Verisk Analytics (VRSK)
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
